FI941317A - Förfarande för framställning av en liposomdispersion under högtrycksförhållanden - Google Patents

Förfarande för framställning av en liposomdispersion under högtrycksförhållanden Download PDF

Info

Publication number
FI941317A
FI941317A FI941317A FI941317A FI941317A FI 941317 A FI941317 A FI 941317A FI 941317 A FI941317 A FI 941317A FI 941317 A FI941317 A FI 941317A FI 941317 A FI941317 A FI 941317A
Authority
FI
Finland
Prior art keywords
substances
preparing
mixtures
soluble
high pressure
Prior art date
Application number
FI941317A
Other languages
English (en)
Finnish (fi)
Other versions
FI941317A0 (sv
FI111687B (sv
Inventor
Lene Frederiksen
Klaus Anton
Hoogevest Peter Van
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of FI941317A0 publication Critical patent/FI941317A0/sv
Publication of FI941317A publication Critical patent/FI941317A/sv
Application granted granted Critical
Publication of FI111687B publication Critical patent/FI111687B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1277—Processes for preparing; Proliposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
FI941317A 1993-03-24 1994-03-21 Förfarande för framställning av en liposomdispersion under högtrycksförhållanden FI111687B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH89193 1993-03-24
CH89193 1993-03-24

Publications (3)

Publication Number Publication Date
FI941317A0 FI941317A0 (sv) 1994-03-21
FI941317A true FI941317A (sv) 1994-09-25
FI111687B FI111687B (sv) 2003-09-15

Family

ID=4197591

Family Applications (1)

Application Number Title Priority Date Filing Date
FI941317A FI111687B (sv) 1993-03-24 1994-03-21 Förfarande för framställning av en liposomdispersion under högtrycksförhållanden

Country Status (15)

Country Link
US (1) US5700482A (sv)
EP (1) EP0616801B1 (sv)
JP (1) JPH06315624A (sv)
KR (1) KR940021050A (sv)
AT (1) ATE166573T1 (sv)
AU (1) AU676257B2 (sv)
CA (1) CA2119610C (sv)
DE (1) DE59406065D1 (sv)
FI (1) FI111687B (sv)
HU (1) HU219352B (sv)
IL (1) IL109070A (sv)
NO (1) NO306846B1 (sv)
NZ (1) NZ260154A (sv)
PH (1) PH30470A (sv)
ZA (1) ZA942037B (sv)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0706821A1 (en) * 1994-10-06 1996-04-17 Centre De Microencapsulation Method of coating particles
CA2205500A1 (en) * 1994-11-18 1996-05-30 Aphios Corporation Methods and apparatus for making liposomes containing hydrophobic drugs
DE4445341A1 (de) * 1994-12-19 1996-06-20 Basf Ag Verfahren und Vorrichtung zur Herstellung wirkstoffhaltiger Dispersionen
US6375930B2 (en) 1996-06-04 2002-04-23 Board Of Regents, The University Of Texas System Membrane incorporation of texaphyrins
DE19639811A1 (de) * 1996-09-27 1998-04-02 Artur Herzog Dr Mesmer Verwendung einer Liposomenlösung zur Verstärkung der Wirksamkeit und/oder Verminderung der Toxizität von Arzneimitteln
DE19711393C1 (de) * 1997-03-19 1998-08-13 Fraunhofer Ges Forschung Verfahren zum Mikroverkapseln von Partikeln
DK1014946T3 (da) 1997-09-18 2010-06-28 Pacira Pharmaceuticals Inc Liposomale anæstetiske sammensætninger med forsinket frigivelse
EP1030652B1 (en) 1997-11-14 2012-04-25 Pacira Pharmaceuticals, Inc. Production of multivesicular liposomes
AU2868099A (en) * 1998-02-13 1999-08-30 Selective Genetics, Inc. Concurrent flow mixing methods and apparatuses for the preparation of gene therapy vectors and compositions prepared thereby
US6706280B2 (en) * 1998-08-19 2004-03-16 Bracco Research S.A. Carboxylated phosphatidic acid esters
AU756196B2 (en) * 1998-11-13 2003-01-09 Optime Therapeutics, Inc. Method and apparatus for liposome production
US6855296B1 (en) 1998-11-13 2005-02-15 Optime Therapeutics, Inc. Method and apparatus for liposome production
FR2803539B1 (fr) * 2000-01-07 2002-07-12 Separex Sa Procede de captage et d'encapsulation de fines particules
DE60142487D1 (de) * 2000-10-13 2010-08-12 Nat Inst Of Advanced Ind Scien Verfahren zur herstellung von liposomen
EP1361863A2 (en) * 2001-02-13 2003-11-19 Yissum Research Development Company Of The Hebrew University Of Jerusalem Carotenoid-loaded liposomes
WO2002089851A1 (fr) * 2001-03-06 2002-11-14 Separex (Societe Anonyme) Procede de fabrication de complexes hote-client
FR2830760B1 (fr) * 2001-10-12 2004-06-04 Pf Medicament Procede de preparation d'un compose d'interaction de substances actives avec un support poreux par fluide supercritique
FR2854079B1 (fr) * 2003-04-25 2007-11-30 Pf Medicament Procede de preparation de complexes moleculaires
JP4595319B2 (ja) * 2003-12-03 2010-12-08 コニカミノルタエムジー株式会社 リポソーム用脂質、リポソームおよびそれらの製造方法
CA3031283A1 (en) 2004-01-22 2005-08-04 University Of Miami Topical co-enzyme q10 formulations and methods of use
JP4649841B2 (ja) * 2004-02-18 2011-03-16 コニカミノルタエムジー株式会社 リポソーム含有製剤の製造方法、およびリポソーム含有製剤
US7588751B2 (en) * 2004-07-21 2009-09-15 Konica Minolta Medical & Graphic, Inc. Liposome-containing radiographic contrast medium and preparation method thereof
JP5176320B2 (ja) * 2004-08-11 2013-04-03 コニカミノルタエムジー株式会社 リポソーム含有製剤の製造方法
JP2006056807A (ja) * 2004-08-18 2006-03-02 Konica Minolta Medical & Graphic Inc 光線力学療法製剤
JP4715133B2 (ja) * 2004-08-26 2011-07-06 コニカミノルタエムジー株式会社 抗腫瘍リポソーム製剤およびその製造方法
JP2006069929A (ja) * 2004-08-31 2006-03-16 Konica Minolta Medical & Graphic Inc 真菌症治療製剤およびその製造方法
WO2006071659A1 (en) * 2004-12-29 2006-07-06 Trustees Of Boston University Delivery of h2 antagonists
TW200726858A (en) * 2005-04-15 2007-07-16 Advanced Tech Materials Apparatus and method for supercritical fluid removal or deposition processes
JP2006298838A (ja) * 2005-04-21 2006-11-02 Konica Minolta Medical & Graphic Inc リポソーム含有ｘ線造影剤
FR2889665B1 (fr) * 2005-08-12 2007-11-09 Pic Solution Soc Par Actions S Procede et installation pour la regulation du taux de modificateur dans une chromatographie ou extraction supercritique avec recyclage
JP2007217369A (ja) * 2006-02-17 2007-08-30 Trendy:Kk 除毛剤、除毛剤の製造方法、および除毛方法
MX337408B (es) 2007-03-22 2016-03-03 Berg Llc Formulaciones topicas que tienen biodisponibilidad aumentada.
EP2271325A4 (en) 2008-04-11 2011-11-09 Cytotech Labs Llc METHODS AND USE OF INDUCING APOPTOSIS IN CANCER CELLS
US9445975B2 (en) 2008-10-03 2016-09-20 Access Business Group International, Llc Composition and method for preparing stable unilamellar liposomal suspension
KR20180056816A (ko) 2009-05-11 2018-05-29 베르그 엘엘씨 환경대사적 전환인자（조효소 ｑ１０）를 사용한 질환의 치료 방법
EP2544663B1 (en) * 2010-03-12 2018-01-03 Berg LLC Intravenous formulations of coenzyme q10 (coq10) and methods of use thereof
JP6092844B2 (ja) 2011-04-04 2017-03-08 バーグ エルエルシー 中枢神経系腫瘍の治療方法
MY183615A (en) 2011-06-17 2021-03-03 Berg Llc Inhalable pharmaceutical compositions
BR112014015333A2 (pt) 2011-12-22 2017-06-13 Nuvo Res Gmbh composições lipossomais de clorito ou clorato
NZ713868A (en) 2013-04-08 2021-12-24 Berg Llc Treatment of cancer using coenzyme q10 combination therapies
SG10201907816RA (en) 2013-09-04 2019-09-27 Berg Llc Methods of treatment of cancer by continuous infusion of coenzyme q10
JP6316182B2 (ja) * 2014-12-19 2018-04-25 富士フイルム株式会社 リポソームの製造方法及びリポソーム製造装置
WO2019088193A1 (ja) * 2017-11-01 2019-05-09 国立大学法人大阪大学 所望の粒径を有する脂質粒子を製造するための方法および装置の開発
WO2019191627A1 (en) 2018-03-30 2019-10-03 Insmed Incorporated Methods for continuous manufacture of liposomal drug products
US11278494B1 (en) 2021-01-22 2022-03-22 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US11033495B1 (en) 2021-01-22 2021-06-15 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US11357727B1 (en) 2021-01-22 2022-06-14 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
CN114469734B (zh) * 2021-10-13 2023-08-04 成都科建生物医药有限公司 一种蒽环类药物脂质体的制备装置与制备方法
CN114469733B (zh) * 2021-10-13 2023-06-09 成都科建生物医药有限公司 一种阿霉素脂质体的制备装置与制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8322178D0 (en) * 1983-08-17 1983-09-21 Sterwin Ag Preparing aerosol compositions
CA1260393A (en) * 1984-10-16 1989-09-26 Lajos Tarcsay Liposomes of synthetic lipids
AU598601B2 (en) * 1986-09-18 1990-06-28 Liposome Technology, Inc. High-concentration liposome processing method
US4752425A (en) * 1986-09-18 1988-06-21 Liposome Technology, Inc. High-encapsulation liposome processing method
DE3812816A1 (de) * 1988-04-16 1989-11-02 Lawaczeck Ruediger Dipl Phys P Verfahren zur solubilisierung von liposomen und/oder biologischer membranen sowie deren verwendung
US5123414A (en) * 1989-12-22 1992-06-23 Unger Evan C Liposomes as contrast agents for ultrasonic imaging and methods for preparing the same
US5270053A (en) * 1990-04-03 1993-12-14 Ciba-Geigy Corp. Parenterally administerable liposome formulation comprising synthetic lipid

Also Published As

Publication number Publication date
ATE166573T1 (de) 1998-06-15
KR940021050A (ko) 1994-10-17
EP0616801A1 (de) 1994-09-28
IL109070A (en) 1998-04-05
JPH06315624A (ja) 1994-11-15
AU676257B2 (en) 1997-03-06
CA2119610A1 (en) 1994-09-25
PH30470A (en) 1997-05-28
DE59406065D1 (de) 1998-07-02
AU5788894A (en) 1994-09-29
EP0616801B1 (de) 1998-05-27
IL109070A0 (en) 1994-06-24
NO941054D0 (no) 1994-03-23
FI941317A0 (sv) 1994-03-21
CA2119610C (en) 2003-07-08
NZ260154A (en) 1995-08-28
HUT67384A (en) 1995-04-28
NO941054L (no) 1994-09-26
NO306846B1 (no) 2000-01-03
FI111687B (sv) 2003-09-15
ZA942037B (en) 1994-09-26
US5700482A (en) 1997-12-23
HU219352B (en) 2001-03-28
HU9400827D0 (en) 1994-06-28

Similar Documents

Publication Publication Date Title
FI941317A (sv) Förfarande för framställning av en liposomdispersion under högtrycksförhållanden
CA2241054A1 (en) Method and apparatus for applying volatile substances to materials
ATE109435T1 (de) Verarbeitungsverfahren für organische substanzen.
ATE88093T1 (de) Ausscheidung von prozesschemikalien aus biologischen gemischen mit halogenierten kohlenwasserstoffen.
PL342473A1 (en) Method of obtaining a mixture of lipides and suspension of phopholipides containing such mixture
TR199802789T2 (xx) Eksendin analoglar� bunlar�n �retimi i�in y�ntemler ve bunlar� i�eren farmas�tik m�stahzarlar.
RU94040889A (ru) Способ получения перфторполиэфиров
AU626714B2 (en) Process for the removal of cholesterol or cholesterol esters from foodstuffs
BG106689A (en) Method for the production of particles
RU93004547A (ru) Фармацевтический состав на основе tanacetum partheniom, способ его получения и лекарственное средство на его основе
GR3018064T3 (en) Aqueous phospholipid vesicle dispersion, process for its manufacture and use thereof.
AU7379687A (en) A process for obtaining active proteins from a biologically inactive form
ES2193134T3 (es) Procedimiento para la preparacion de dispersiones de vesiculas encapsuladas.
AU8816098A (en) Process for preparing contrast agents
UA27708C2 (uk) Аерозольний препарат та спосіб його одержання
AU7404191A (en) Process for the separation of yttrium
CN111233992A (zh) 人工活化的肽

Legal Events

Date Code Title Description
GB Transfer or assigment of application

Owner name: NOVARTIS AG

MA Patent expired